Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six Week Extended-Dose Nevirapine (SWEN) Study
NCT00074399Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2001
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Nevirapine 6 weeks with Placebo 6 weeks (2 arms). Primary endpoint: Infant HIV infection status at 12 months. Started Feb 2001; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00074399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074399.